Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Silo Pharma, Inc. | Financial_Report.xls |
| EX-32.1 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc. | f10q0911ex32i_goldswap.htm |
| EX-31.2 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc. | f10q0911ex31ii_goldswap.htm |
| 10-Q - QUARTERLY REPORT - Silo Pharma, Inc. | f10q0911_goldswap.htm |
| EX-31.1 - CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT - Silo Pharma, Inc. | f10q0911ex31i_goldswap.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
The undersigned, Donald Ptalis, Chief Financial Officer and Director of Gold Swap Inc. (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: November 10, 2011
|
By:
|
/s/ Donald Ptalis | ||
| Name: | Donald Ptalis | ||
| Title: | Chief Financial Officer and Director (Principal Financial &Accounting Officer) | ||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.